Taking Ozempic and worried about vision loss? This test can help you understand your risk.

InvestorsWire newsroom brief · 1h ago · 1 min read · via marketwatch.com

Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss. This story matters for Finance & Markets readers tracking finance. Reported by marketwatch.com. Read the full original at the source link below.

Originally reported by marketwatch.com. InvestorsWire curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily finance & markets signal:

More from InvestorsWire

Across the eCorp newsroom network

Part of the eCorp network